<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; vaccine</title>
	<atom:link href="http://oralcancernews.org/wp/tag/vaccine/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Tue, 27 Jul 2010 19:28:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Vaccines might help fight throat cancer, but hurdles are high</title>
		<link>http://oralcancernews.org/wp/vaccines-might-help-fight-throat-cancer-but-hurdles-are-high/</link>
		<comments>http://oralcancernews.org/wp/vaccines-might-help-fight-throat-cancer-but-hurdles-are-high/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 03:21:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9171</guid>
		<description><![CDATA[
			
				
			
		
Source: www.npr.org
Author: Chao Deng
There&#8217;s been a big and controversial push to protect girls from cervical cancer by vaccinating them against the human papillomavirus. Turns out, the same vaccine might also protect boys from developing throat cancer later in life.
Researchers estimate HPV causes more than 11,000 cases of throat  cancers in the U.S. each year. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/vaccines-might-help-fight-throat-cancer-but-hurdles-are-high/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nicotine vaccine shows effectiveness in early tests</title>
		<link>http://oralcancernews.org/wp/nicotine-vaccine-shows-effectiveness-in-early-tests/</link>
		<comments>http://oralcancernews.org/wp/nicotine-vaccine-shows-effectiveness-in-early-tests/#comments</comments>
		<pubDate>Thu, 22 Apr 2010 18:37:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[cigarettes]]></category>
		<category><![CDATA[dopamine]]></category>
		<category><![CDATA[nicotine]]></category>
		<category><![CDATA[NicVAX]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8466</guid>
		<description><![CDATA[
			
				
			
		
Source: CNN
Author: Val Willingham
(CNN) &#8212; A vaccine that could help people stop smoking is  showing promise in early clinical trials, researchers announced this  week at a national meeting of addiction specialists.
The vaccine  is designed to stimulate the immune system to generate antibodies that  would latch on to nicotine in a smoker&#8217;s [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/nicotine-vaccine-shows-effectiveness-in-early-tests/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Another call to extend HPV vaccine to boys. Is anyone listening?</title>
		<link>http://oralcancernews.org/wp/call-to-extend-hpv-vaccine-to-boys/</link>
		<comments>http://oralcancernews.org/wp/call-to-extend-hpv-vaccine-to-boys/#comments</comments>
		<pubDate>Fri, 02 Apr 2010 02:49:50 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8242</guid>
		<description><![CDATA[
			
				
			
		
Source: www.abc.net.au
Author: Lindy Kerin
Australian researchers say the human papillomavirus (HPV), which can cause cervical cancer in women, is now a leading cause of oral cancer in men in the Western world. The news has reignited debate over whether the HPV vaccine, which is free for young women, should also be offered to men.
A University of [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/call-to-extend-hpv-vaccine-to-boys/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Needed: HPV vaccine, simple screening test, for women and men</title>
		<link>http://oralcancernews.org/wp/needed-hpv-vaccine-simple-screening-test-for-women-and-men/</link>
		<comments>http://oralcancernews.org/wp/needed-hpv-vaccine-simple-screening-test-for-women-and-men/#comments</comments>
		<pubDate>Sat, 20 Mar 2010 04:39:40 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[early detection]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV- associated cancers]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[Maura Gillison]]></category>
		<category><![CDATA[oral rinses]]></category>
		<category><![CDATA[oral screening]]></category>
		<category><![CDATA[swish and spit]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8156</guid>
		<description><![CDATA[
			
				
			
		
Source: jhu.edu/~gazette
Author: Valerie Mehl, Johns Hopkins Medicine
A call to explore a broader use of human papillomavirus vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by an investigator at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Leading HPV expert Maura Gillison, the first to [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/needed-hpv-vaccine-simple-screening-test-for-women-and-men/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV vaccine reduced further disease in women treated for cancer precursors</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-reduced-further-disease-in-women-treated-for-cancer-precursors/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-reduced-further-disease-in-women-treated-for-cancer-precursors/#comments</comments>
		<pubDate>Thu, 18 Mar 2010 03:02:24 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Gardisil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[intraepithelial neoplasia]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8130</guid>
		<description><![CDATA[
			
				
			
		
Source: www.hemonctoday.com
Author:  staff
HPV vaccine quadrivalent (types 6, 11, 16 and 18) decreased HPV-related disease in women previously treated for cancer precursors, according to the post-hoc analysis of findings from two trials. 
Warner Huh, MD, associate professor in the department of obstetrics and gynecology at the University of Alabama at Birmingham, presented these findings at [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-reduced-further-disease-in-women-treated-for-cancer-precursors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV-related cancer not confined to cervix</title>
		<link>http://oralcancernews.org/wp/hpv-related-cancer-not-confined-to-cervix/</link>
		<comments>http://oralcancernews.org/wp/hpv-related-cancer-not-confined-to-cervix/#comments</comments>
		<pubDate>Fri, 12 Mar 2010 02:12:43 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[National Comprehensive Cancer Network]]></category>
		<category><![CDATA[penile cancer]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[tobacco]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8099</guid>
		<description><![CDATA[
			
				
			
		
Source: www.businesswire.com
Author: press release
The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer. Expert physicians from the National Comprehensive Cancer Network (NCCN) Member Institutions presented an update on HPV and its link to various cancers including cervical cancer, anal carcinoma, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-related-cancer-not-confined-to-cervix/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BT Pharma secures EUR 13.1million (USD 17.7 million) in capital funding and changes its name to Genticel</title>
		<link>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/</link>
		<comments>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 04:40:51 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[HPV18]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[immunotherapies]]></category>
		<category><![CDATA[ProCervix]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8085</guid>
		<description><![CDATA[
			
				
			
		
Source: pharmalive.com/News
Author: press release
BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional de Développement [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New vaccine against HPV approved in Canada</title>
		<link>http://oralcancernews.org/wp/new-vaccine-against-hpv-approved-in-canada/</link>
		<comments>http://oralcancernews.org/wp/new-vaccine-against-hpv-approved-in-canada/#comments</comments>
		<pubDate>Thu, 11 Feb 2010 16:55:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV 31]]></category>
		<category><![CDATA[HPV 45]]></category>
		<category><![CDATA[HPV-11]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[HPV-33]]></category>
		<category><![CDATA[HPV-6]]></category>
		<category><![CDATA[Pap screening]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7847</guid>
		<description><![CDATA[
			
				
			
		
Source: www.ctv.ca
Author: staff
Canadian women have a choice of two vaccines against HPV, the family of viruses that can cause cervical cancer, now that Health Canada has approved GlaxoSmithKline&#8217;s vaccine, Cervarix.
The vaccine, which is expected to be available by the end of the month, will compete against Gardasil, a product of Merck Canada, which has been [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-vaccine-against-hpv-approved-in-canada/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Two doctors explain their support of the Gardasil vaccine</title>
		<link>http://oralcancernews.org/wp/two-doctors-explain-their-support-of-the-gardasil-vaccine/</link>
		<comments>http://oralcancernews.org/wp/two-doctors-explain-their-support-of-the-gardasil-vaccine/#comments</comments>
		<pubDate>Sat, 09 Jan 2010 19:13:34 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[drug companies]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[immunity]]></category>
		<category><![CDATA[intraepithelial neoplasia]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[pathogenesis]]></category>
		<category><![CDATA[severe reactions]]></category>
		<category><![CDATA[STDs]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7702</guid>
		<description><![CDATA[
			
				
			
		
Source: www.huffingtonpost.com
Author: Marcia G. Yerman
As parents contemplate whether or not they should have the Gardasil vaccine administered to their daughters, one of the first places that they turn is to their doctors. In this segment, I posed questions to two doctors supporting the vaccine.
Dr. Margaret Lewin, M.D., F.A.C.P., is the Medical Director of Cinergy Health, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/two-doctors-explain-their-support-of-the-gardasil-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Liverpool scientists working on vaccine for mouth cancer</title>
		<link>http://oralcancernews.org/wp/liverpool-scientists-working-on-vaccine-for-mouth-cancer/</link>
		<comments>http://oralcancernews.org/wp/liverpool-scientists-working-on-vaccine-for-mouth-cancer/#comments</comments>
		<pubDate>Mon, 04 Jan 2010 15:31:39 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7689</guid>
		<description><![CDATA[
			
				
			
		
Source: www.liverpoolecho.co.uk
Author:  Liza Williams
ONE central project the scientists and doctors are working on is a vaccine for mouth cancer. Liverpool researchers have found some cases are caused by the HPV virus – the same bug which causes cervical cancer. They have discovered that two-thirds of tonsil cancer tumour samples showed evidence of the HPV-16 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/liverpool-scientists-working-on-vaccine-for-mouth-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cervarix® vaccination against HPV lasts at least six years</title>
		<link>http://oralcancernews.org/wp/cervarix%c2%ae-vaccination-against-hpv-lasts-at-least-six-years/</link>
		<comments>http://oralcancernews.org/wp/cervarix%c2%ae-vaccination-against-hpv-lasts-at-least-six-years/#comments</comments>
		<pubDate>Mon, 07 Dec 2009 23:52:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7534</guid>
		<description><![CDATA[
			
				
			
		
Source: professional.cancerconsultants.com
Author: staff
Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.[1]
Cervarix [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cervarix%c2%ae-vaccination-against-hpv-lasts-at-least-six-years/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Implant-based cancer vaccine is first to eliminate tumors in mice</title>
		<link>http://oralcancernews.org/wp/implant-based-cancer-vaccine-is-first-to-eliminate-tumors-in-mice/</link>
		<comments>http://oralcancernews.org/wp/implant-based-cancer-vaccine-is-first-to-eliminate-tumors-in-mice/#comments</comments>
		<pubDate>Tue, 01 Dec 2009 22:36:50 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cytokines]]></category>
		<category><![CDATA[dendritic cells]]></category>
		<category><![CDATA[immunotherapies]]></category>
		<category><![CDATA[implant]]></category>
		<category><![CDATA[lymph nodes]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7494</guid>
		<description><![CDATA[
			
				
			
		
Source: news.biocompare.com
Authors: David J. Mooney et al.
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal Science Translational Medicine.
The new approach, pioneered by bioengineers and immunologists at Harvard University, uses plastic disks impregnated with tumor-specific antigens [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/implant-based-cancer-vaccine-is-first-to-eliminate-tumors-in-mice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Should your son get the HPV vaccine?</title>
		<link>http://oralcancernews.org/wp/should-your-son-get-the-hpv-vaccine/</link>
		<comments>http://oralcancernews.org/wp/should-your-son-get-the-hpv-vaccine/#comments</comments>
		<pubDate>Sat, 28 Nov 2009 14:19:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7434</guid>
		<description><![CDATA[
			
				
			
		
Source: www.nbc-2.com
Author: staff
TAMPA: David Hastings is back to helping his wife Jo at their Cuban restaurant outside Saint Petersburg. He&#8217;s grateful to be here after a very close call.
&#8220;One morning I was shaving and I noticed this side of my neck was swollen,&#8221; Hastings explained.
The diagnosis: stage four oral cancer. Until then, David was a [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/should-your-son-get-the-hpv-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>After being diagnosed, Zenk Pinter is an oral cancer spokesperson</title>
		<link>http://oralcancernews.org/wp/after-being-diagnosed-zenk-pinter-is-an-oral-cancer-spokesperson/</link>
		<comments>http://oralcancernews.org/wp/after-being-diagnosed-zenk-pinter-is-an-oral-cancer-spokesperson/#comments</comments>
		<pubDate>Sat, 28 Nov 2009 14:11:44 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Barbara Ryan]]></category>
		<category><![CDATA[Colleen Zenk Pinter]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7429</guid>
		<description><![CDATA[
			
				
			
		
Source: www.acorn-online.com
Author: Susan Wolf 
Colleen Zenk Pinter of Redding, an actor who stars as Barbara Ryan on As the World Turns, has partnered with the Oral Cancer Foundation, Yale New-Haven Hospital and Roswell Park Cancer Institute to be a spokesperson for oral cancer. Ms. Pinter was diagnosed with oral cancer in March 2007 and is [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/after-being-diagnosed-zenk-pinter-is-an-oral-cancer-spokesperson/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV vaccine clears viral infection and may reduce cancerous lesions</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 03:37:37 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[regression]]></category>
		<category><![CDATA[synthetic long peptides]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7304</guid>
		<description><![CDATA[
			
				
			
		
Source: www.newswise.com
Author: staff
Breakthrough study reports complete and partial remissions following vaccination
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. 
According to a report published in the November 5 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
